TMEM44-AS1
gene geneOn this page
Summary
TMEM44-AS1 (TMEM44 antisense RNA 1, HGNC:44272) is a long non-coding RNA gene on chromosome 3q29.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:44272 |
| Approved symbol | TMEM44-AS1 |
| Name | TMEM44 antisense RNA 1 |
| Location | 3q29 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000231770 |
| Ensembl biotype | lncRNA |
| Entrez | 100507297 |
| RNAcentral | URS000075DE24 — lncRNA, 1433 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 9 lncRNA
ENST00000419571, ENST00000447982, ENST00000453671, ENST00000693189, ENST00000737518, ENST00000737519, ENST00000737520, ENST00000737521, ENST00000737522
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000419571 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001637884 | 194589855 | 194590249 |
| ENSE00001778581 | 194584299 | 194584448 |
| ENSE00002527435 | 194589025 | 194589142 |
Expression profiles
Bgee: expression breadth ubiquitous, 203 present calls, max score 85.96.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.5921 / max 101.1359, expressed in 1643 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 40663 | 6.4803 | 1636 |
| 40664 | 0.1118 | 44 |
Top tissues by expression
239 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.96 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 82.09 | gold quality |
| sural nerve | UBERON:0015488 | 82.09 | gold quality |
| islet of Langerhans | UBERON:0000006 | 81.63 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 81.56 | gold quality |
| right lobe of liver | UBERON:0001114 | 81.51 | gold quality |
| pancreatic ductal cell | CL:0002079 | 81.48 | gold quality |
| adenohypophysis | UBERON:0002196 | 81.34 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 80.73 | gold quality |
| body of pancreas | UBERON:0001150 | 80.35 | gold quality |
| metanephros cortex | UBERON:0010533 | 80.20 | gold quality |
| thyroid gland | UBERON:0002046 | 80.16 | gold quality |
| pancreas | UBERON:0001264 | 80.13 | gold quality |
| right uterine tube | UBERON:0001302 | 80.12 | gold quality |
| tibial nerve | UBERON:0001323 | 80.10 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 80.08 | gold quality |
| calcaneal tendon | UBERON:0003701 | 79.76 | gold quality |
| right adrenal gland | UBERON:0001233 | 79.71 | gold quality |
| monocyte | CL:0000576 | 79.60 | gold quality |
| pituitary gland | UBERON:0000007 | 79.46 | gold quality |
| leukocyte | CL:0000738 | 79.41 | gold quality |
| granulocyte | CL:0000094 | 79.15 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 78.92 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 78.69 | gold quality |
| left adrenal gland | UBERON:0001234 | 78.56 | gold quality |
| apex of heart | UBERON:0002098 | 78.13 | gold quality |
| spinal cord | UBERON:0002240 | 78.04 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 77.99 | gold quality |
| body of stomach | UBERON:0001161 | 77.96 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 77.88 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.96 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc. (PMID:34696771)
- Chitosan-Gelatin-EGCG Nanoparticle-Meditated LncRNA TMEM44-AS1 Silencing to Activate the P53 Signaling Pathway for the Synergistic Reversal of 5-FU Resistance in Gastric Cancer. (PMID:35717675)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.